top of page

​Conference Chairman's Lecture

大会長講演 糸川 昌成

May 20 (Sat)  9:20AM〜

Masanari Itokawa
Deputy Director, Tokyo Metropolitan Institute of Medical Science

Born June 21, 1961 Tokyo Male 60 years old

1989 Graduated from Saitama Medical University
Department of Neuropsychiatry, Tokyo Medical and Dental University

Resident (Professor Yudoo)
1990   Psychiatry Department, Yotsukura Hospital, Fukushima Prefecture Full-time doctor
1991   Department of Human Genetics, University of Tsukuba

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Research Student (Associate Professor Tadao Ariwa)
1993   Department of Neuropsychiatry, Tokyo Medical and Dental University

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Doctor (Professor Yudoo)
1994   Department of Biochemistry, Brain Research Institute, University of Tokyo

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Research Student (Professor Tatsuya Haga)
1996   Molecular Neurobiology Branch,

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     National Institute on Drug Abuse,

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     National Institutes of Health,

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Visiting Fellow (Professor George Uhl)
1999 RIKEN Molecular Psychiatry Research Team

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Researcher(Takeo Yoshikawa Team Leader)
2001 Division of Schizophrenia, Tokyo Metropolitan Institute of Psychiatry

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Department Head (Deputy Counselor)
Part-time doctor, Department of Psychiatry, Matsuzawa Metropolitan Hospital
2004   Tokyo Metropolitan Institute of Psychiatry

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Schizophrenia Project

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Project Leader.(Deputy Counselor)
2011 Tokyo Metropolitan Institute of Medical Science (Integrated transfer of research institutes)
Schizophrenia/Depression Project

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Project leader (counselor)

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Chief
2015    President of the 10th Annual Meeting of the Japanese Society for Schizophrenia
Tokyo Metropolitan Institute of Medical Science

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Director of Hospital Collaborative Research Center
2018 Tokyo Metropolitan Institute of Medical Science

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     Deputy Director
2020   Tokyo Metropolitan Institute of Medical Science

          _cc781905-5cde-3194 -bb3b-136bad5cf58d_     New Corona Countermeasures Special Team General Manager

Specialties: Psychiatry, molecular biology, philosophy of science, currently interested in Edo period economic policies, Zen Buddhism, and folklore.
Hobbies: Taking and appreciating photos, Iai, skiing, swimming, playing catch at the office during lunch break, reading, listening to music

1989 Chairman Moroyama Award (Saitama Medical University)
1992   Shimazaki-Shimazono-Takahashi Academic Award (Tokyo Medical and Dental University)
2008     Tokyo Governor Award (Invention Discovery)
2011     Schizophrenia Study Group Grand Prize
2016     Healthy Society Award (Japanese Nursing Association)

Director of the Japanese Society for Schizophrenia, President of the 10th Annual Meeting of the Japanese Society for Schizophrenia
Director of Japanese Society of Psychoneuropharmacology
Councilor, Japanese Society of Biological Psychiatry
Visiting Professor, Graduate School of Frontier Sciences, The University of Tokyo
Saitama Medical University part-time lecturer

“Why Clinicians Do Research” (Seiwa Shoten), 2013
"Until schizophrenia opens the secret door" (Seiwa Shoten) 2014
"When Scientists Connect Brain and Heart" (Community Mental Health and Welfare Organization) 2015
"Schizophrenia as a Syndrome: A Reexamination from Biological Research" Series Philosophy of Psychiatry, Vol. 1, Chapter 6 (University of Tokyo Press), 2016
"Archaeology of the Brain and Mind" (Nippon Hyoronsha) 2020
Co-authored “Study of Weakness: Understanding the Corona Era with Weakness” (Kumpuru), 2020


main literature
1.    Masanari Itokawa Brain and Mind: Does Molecular Biology Elucidate Mental Illness? Scientific Philosophy 47-2, 2015
2.     Masanari Itokawa Science and Superstition, Schizophrenia no Hiroba No.5 Page161-174,2015
3.     Masanari Itokawa, Makoto Arai, Mitsuhiro Miyashita and others Challenges and Perspectives in Genetic Research of Schizophrenia Heterogeneity and Complex Systems Psychiatry (0488- 1281) Vol.55 No.12 Page1133-1143,2013
4.     Masanari Itokawa, Makoto Arai, Chie Ichikawa et al. 2658) Vol.113 No.7 Page672-678,2011
5.    Miyashita M, Arai M, Kobori A, et al. Clinical features of schizophrenia with en-hanced carbonyl stress.Schizophr Bull.;40(5) :1040-1046, 2014 
6.    Arai M, Yuzawa H, Nohara I, et al. Enhanced carbonyl stress in a subpopulation of schizophrenia.
Arch Gen Psychiatry. ;67(6):589-597, 2010
7.    Sora I, Hall FS, Andrews AM, et al. Molecular mechanisms of cocaine reward: com-bined dopamine and serotonin transporter knockouts eliminate cocaine place prefer- ence.
Proc Natl Acad Sci US A. 24;98(9):5300-5305, 2001
8.    Lin Z, Itokawa M, Uhl GR. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.FASEB J.;14(5 ): 715-728, 2000
9.    Itokawa M, Toru M, Ito K, et al Sequestration of the short and long isoforms of do-pamine D2 receptors expressed in Chinese hamster ovary cells. Mol Pharma-col.  ;49(3):560-566, 1996
10.    Arinami T, Itokawa M, Enguchi H, et al. Association of dopamine D2 receptor molecu-lar variant with schizophrenia.Lancet. 19;343(8899 ): 703-704.1994


bottom of page